Acetylcholine and the alpha 7 nicotinic receptor: A potential therapeutic target for the treatment of periodontal disease?

Inflammation Research

Volumn 61, Issue 9, 2012, Pages 915-926

  Zoheir, Noha ^a   Lappin, David F ^a   Nile, Christopher J ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

Acetylcholine; Alpha 7 nicotinic receptor; Inflammation; Periodontal disease

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; ACETYLCHOLINE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR AGONIST; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; NICOTINE; SPIRO[1 AZABICYCLO[2.2.2]OCTANE 3,2' THIAZOLIDINE] 2' ONE; TC 7020; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ASTHMA; AUTOCRINE EFFECT; CELLULAR IMMUNITY; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; CYTOKINE PRODUCTION; DISEASE CONTROL; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENTERITIS; GINGIVITIS; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; MOUTH HYGIENE; NEUROMODULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREATITIS; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS;

ACETYLCHOLINE; ANIMALS; HUMANS; NICOTINE; PERIODONTAL DISEASES; PERIODONTIUM; RECEPTORS, NICOTINIC;

EID: 84865123233     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0513-z     Document Type: Review

References (72)

1. Kelly M SJ, Nuttall N et al. The condition of supporting structures. In: Walker A, Cooper I, editors. Adult dental health survey. Oral health in the United Kingdom, vol. 2000. London: Stationary office Books; 1998. p. 123-146.
2. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol. 2008;79:1585-91.
3. Preshaw PM. Host response modulation in periodontics. Periodontology. 2000;2008(48):92-110.
4. Fujii T, Takada-Takatori Y, Kawashima K. Basic and clinical aspects of non-neuronal acetylcholine: expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J Pharmacol Sci. 2008;106:186-92. (Pubitemid 351366336)
5. Klapproth H, Reinheimer T, Metzen J, et al. Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol. 1997;355: 515-23. (Pubitemid 27140478)
6. Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol. 2008;154:1558-71.
7. VP W. Identification of acetylcholine and related esters of biological origin. In: Eichler O, Farah A, Koelle GB, editors. Handbuch Der Experimentellen Pharmakologie., vol. 15; p. 1-39.
8. Wessler I, Kilbinger H, Bittinger F, Unger R, Kirkpatrick CJ. The non-neuronal cholinergic system in humans: expression, function and pathophysiology. Life Sci. 2003;72:2055-61. (Pubitemid 36298947)
9. Kawashima K, Fujii T. Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. J Pharmacol Sci. 2008;106:167-73. (Pubitemid 351366333)
10. Wessler I, Roth E, Schwarze S, et al. Release of non-neuronal acetylcholine from the human placenta: difference to neuronal acetylcholine. Naunyn Schmiedebergs Arch Pharmacol. 2001; 364:205-12. (Pubitemid 32802148)
11. Wessler I, Roth E, Deutsch C, et al. Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters. Br J Pharmacol. 2001;134:951-6. (Pubitemid 33052153)
12. Ishii M, Kurachi Y. Muscarinic acetylcholine receptors. Curr Pharm Des. 2006;12:3573-81. (Pubitemid 44509627)
13. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009;89:73-120.
14. Nguyen VT, Hall LL, Gallacher G, et al. Choline acetyltransferase, acetylcholinesterase, and nicotinic acetylcholine receptors of human gingival and esophageal epithelia. J Dent Res. 2000;79:939-49. (Pubitemid 32501305)
15. Brayton JJ, Yang Q, Nakkula RJ, Walters JD. An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells. J Periodontol. 2002;73:1267-72. (Pubitemid 35469673)
16. Grando SA, Kist DA, Qi M, Dahl MV. Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol. 1993;101:32-6. (Pubitemid 23213008)
17. Rajeswari KR, Satyanarayana M. Cholinergic components in human gingiva in healthy and inflamed states. Indian J Dent Res. 1990;2:166-9.
18. Arredondo J, Hall LL, Ndoye A, Chernyavsky AI, Jolkovsky DL, Grando SA. Muscarinic acetylcholine receptors regulating cell cycle progression are expressed in human gingival keratinocytes. J Periodontal Res. 2003;38:79-89. (Pubitemid 37463601)
19. Wang XJ, Liu YF, Wang QY, et al. Functional expression of alpha 7 nicotinic acetylcholine receptors in human periodontal ligament fibroblasts and rat periodontal tissues. Cell Tissue Res. 2010;340:347-55.
20. Thangjam GS, Kondaiah P. Regulation of oxidative-stress responsive genes by arecoline in human keratinocytes. J Periodontal Res. 2009;44:673-82.
21. Thangjam GS, Agarwal P, Khan I, et al. Transglutaminase-2 regulation by arecoline in gingival fibroblasts. J Dent Res. 2009;88:170-5.
22. Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA. Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J. 2006;20:2093-101. (Pubitemid 44953908)
23. Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA. Receptor-mediated tobacco toxicity: acceleration of sequential expression of alpha5 and alpha7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke. FASEB J. 2008;22:1356-68. (Pubitemid 351656777)
24. Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA. Receptor-mediated tobacco toxicity: alterations of the NF-kappaB expression and activity downstream of alpha7 nicotinic receptor in oral keratinocytes. Life Sci. 2007;80:2191-4. (Pubitemid 46824132)
25. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med. 2003;9:125-34. (Pubitemid 37310949)
26. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458-62. (Pubitemid 30367422)
27. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384-8. (Pubitemid 36157937)
28. Su X, Matthay MA, Malik AB. Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. J Immunol. 2010;184:401-10.
29. Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004;10:1216-21. (Pubitemid 39540438)
30. Bencherif M, Lippiello PM, Lucas R, Marrero MB. Alpha7 nicotinic receptors as novel therapeutic targets for inflammationbased diseases. Cell Mol Life Sci. 2011;68:931-49.
31. Zhang P, Han D, Tang T, Zhang X, Dai K. Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm Res. 2008;57:322-8.
32. Li T, Zuo X, Zhou Y, et al. The vagus nerve and nicotinic receptors involve inhibition of HMGB1 release and early proinflammatory cytokines function in collagen-induced arthritis. J Clin Immunol. 2010;30:213-20.
33. van Maanen MA, Lebre MC, van der Poll T, et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 2009;60:114-22.
34. Waldburger JM, Boyle DL, Pavlov VA, Tracey KJ, Firestein GS. Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum. 2008;58:3439-49.
35. Westman M, Engstrom M, Catrina AI, Lampa J. Cell specific synovial expression of nicotinic alpha 7 acetylcholine receptor in rheumatoid arthritis and psoriatic arthritis. Scand J Immunol. 2009;70:136-40.
36. van Maanen MA, Stoof SP, van der Zanden EP, et al. The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation. Arthritis Rheum. 2009;60:1272-81.
37. van Maanen MA, Stoof SP, Larosa GJ, Vervoordeldonk MJ, Tak PP. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. Ann Rheum Dis. 2010;69:1717-23.
38. Westman M, Saha S, Morshed M, Lampa J. Lack of acetylcholine nicotine alpha 7 receptor suppresses development of collageninduced arthritis and adaptive immunity. Clin Exp Immunol. 2010;162(1):62-67.
39. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007;21:736-45. (Pubitemid 47002215)
40. Goehler LE, Erisir A, Gaykema RP. Neural-immune interface in the rat area postrema. Neuroscience. 2006;140:1415-34. (Pubitemid 43928278)
41. Stojanovich L, Milovanovich B, de Luka SR, et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune diseases. Lupus. 2007;16:181-5. (Pubitemid 46506595)
42. Bruchfeld A, Goldstein RS, Chavan S, et al. Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis. J Intern Med. 2010;268:94-101.
43. Neumann S, Razen M, Habermehl P, et al. The non-neuronal cholinergic system in peripheral blood cells: effects of nicotinic and muscarinic receptor antagonists on phagocytosis, respiratory burst and migration. Life Sci. 2007;80:2361-4. (Pubitemid 46818263)
44. Greene CM, Ramsay H, Wells RJ, O'Neill SJ, McElvaney NG. Inhibition of Toll-like receptor 2-mediated interleukin-8 production in Cystic Fibrosis airway epithelial cells via the alpha7- nicotinic acetylcholine receptor. Mediators Inflamm. 2010;2010:423241
45. Summers AE, Whelan CJ, Parsons ME. Nicotinic acetylcholine receptor subunits and receptor activity in the epithelial cell line HT29. Life Sci. 2003;72:2091-4. (Pubitemid 36298952)
46. Li Q, Zhou XD, Kolosov VP, Perelman JM. Nicotine reduces TNF-alpha expression through a alpha7 nAChR/MyD88/NF-kB pathway in HBE16 airway epithelial cells. Cell Physiol Biochem. 2011;27:605-12.
47. Toyabe S, Iiai T, Fukuda M, et al. Identification of nicotinic acetylcholine receptors on lymphocytes in the periphery as well as thymus in mice. Immunology. 1997;92:201-5. (Pubitemid 27428447)
48. Yoshikawa H, Kurokawa M, Ozaki N, et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factorkappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol. 2006;146:116-23. (Pubitemid 44393846)
49. de Jonge WJ, van der Zanden EP, The FO, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005;6: 844-51. (Pubitemid 43090471)
50. Chernyavsky AI, Arredondo J, Galitovskiy V, Qian J, Grando SA. Structure and function of the nicotinic arm of acetylcholine regulatory axis in human leukemic T cells. Int J Immunopathol Pharmacol. 2009;22:461-72.
51. Galitovskiy V, Qian J, Chernyavsky AI, et al. Cytokine-induced alterations of alpha7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J Immunol. 2011;187: 2677-87.
52. Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, Brenner T. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol. 2009;183:6681-8.
53. Wang DW, Zhou RB, Yao YM, et al. Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4?CD25? regulatory T cells in mice in vitro. J Pharmacol Exp Ther. 2010;335:553-61.
54. Rosas-Ballina M, Olofsson PS, Ochani M, et al. Acetylcholinesynthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011;334:98-101.
55. Qian J, Galitovskiy V, Chernyavsky AI, Marchenko S, Grando SA. Plasticity of the murine spleen T-cell cholinergic receptors and their role in in vitro differentiation of naive CD4 T cells toward the Th1, Th2 and Th17 lineages. Genes Immun. 2011; 12:222-30.
56. Karimi K, Bienenstock J, Wang L, Forsythe P. The vagus nerve modulates CD4? T cell activity. Brain Behav Immun. 2010; 24:316-23.
57. Skok MV, Kalashnik EN, Koval LN, et al. Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines. Mol Pharmacol. 2003;64:885-9. (Pubitemid 37153057)
58. Skok MV, Grailhe R, Agenes F, Changeux JP. The role of nicotinic receptors in B-lymphocyte development and activation. Life Sci. 2007;80:2334-6. (Pubitemid 46818278)
59. Koval LM, Yu Lykhmus O, Omelchenko DM, Komisarenko SV, Skok MV. The role of alpha7 nicotinic acetylcholine receptors in B lymphocyte activation. Ukr Biokhim Zh. 2009;81:5-11.
60. Koval L, Lykhmus O, Zhmak M, et al. Differential involvement of alpha4beta2, alpha7 and alpha9alpha10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro. Int J Biochem Cell Biol. 2011;43:516-24.
61. Scott DA, Singer DL. Suppression of overt gingival inflammation in tobacco smokers clinical and mechanistic considerations. Int J Dent Hygiene. 2004;2:104-10.
62. Kashiwagi Y, Yanagita M, Kojima Y, et al. Nicotine up-regulates IL-8 expression in human gingival epithelial cells following stimulation with IL-1b or P. gingivalis lipopolysaccharide via nicotinic acetylcholine receptor signaling. Arch Oral Biol. 2011;57(5):483-90.
63. Arredondo J, Chernyavsky AI, Marubio LM, et al. Receptormediated tobacco toxicity: regulation of gene expression through alpha3beta2 nicotinic receptor in oral epithelial cells. Am J Pathol. 2005;166(2):597-613. (Pubitemid 40189055)
64. Breivik T, Gundersen Y, Gjermo P, von Horsten S, Opstad PK. Nicotinic acetylcholine receptor activation mediates nicotineinduced enhancement of experimental periodontitis. J Periodontal Res. 2009;44:297-304.
65. Razani-Boroujerdi S, Behl M, Hahn FF, Pena-Philippides JC, Hutt J, Sopori ML. Role of muscarinic receptors in the regulation of immune and inflammatory responses. J Neuroimmunol. 2008; 194:83-8.
66. Pavlov VA, Ochani M, Yang LH, et al. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med. 2007;35: 1139-44. (Pubitemid 46598966)
67. van Westerloo DJ, Giebelen IA, Florquin S, et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology. 2006;130:1822-30.
68. Su X, Lee JW, Matthay ZA, et al. Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats. Am J Respir Cell Mol Biol. 2007;37:186-92. (Pubitemid 47255001)
69. The FO, Boeckxstaens GE, Snoek SA, et al. Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology. 2007;133:1219-28. (Pubitemid 47494458)
70. Blanchet MR, Israel-Assayag E, Cormier Y. Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist. Eur Respir J. 2005;26:21-7. (Pubitemid 40945927)
71. Marrero MB, Lucas R, Salet C, et al. An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes. J Pharmacol Exp Ther. 2010;332:173-80.
72. Kummer W, Lips KS, Pfeil U. The epithelial cholinergic system of the airways. Histochem Cell Biol. 2008;130:219-34.